Quantitative reverse transcriptase-polymerase chain reaction for prostate-specific antigen mRNA

Clinical Biochemistry

Volumn 30, Issue 5, 1997, Pages 391-397

  Galvan, Barbara ^a   Christopoulos, Theodore K ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA ACTIN; COMPLEMENTARY DNA; DIGOXIGENIN; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; FLUOROMETRY; HUMAN; HUMAN CELL; HYBRIDIZATION; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HUMANS; MALE; POLYMERASE CHAIN REACTION; PROSTATE-SPECIFIC ANTIGEN; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 0031194484     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(97)00010-6     Document Type: Article

References (28)

1. 1. Boring CC, Squires TS, Tong T, Montgomery S. Cancer Statistics, 1994. CA Cancer J Clin 1994; 44: 7-26.
2. 2. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993; 71: 3582-93.
3. 3. Lu-Yao GL, McIerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy. Time trends, geographic variation and outcomes. The Prostate Patient Outcome Research Team. JAMA 1993; 269: 2633-55.
4. 4. Voges GE, McNeal JE, Redwine EA, Freiha FS, Stamey TS. Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarinoma of the prostate. Cancer 1992; 69: 520-6.
5. 5. Carter BS, Carter HB, Isaacs JT. The prostate: an increasing medical problem. Prostate 1990; 16: 187-97.
6. 6. Moreno JG, Croce CM, Fischer R, et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 1992; 52: 6110-12.
7. 7. Deguchi T, Doi T, Ehara H, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse-transcriptase polymerase chain reaction. Cancer Res 1993; 53: 5350-4.
8. 8. Israeli RS, Miller WH Jr., Su SL, et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumour cells: comparison of prostate-specific membrane antigen and prostate specific antigen based assays. Cancer Res 1994; 54: 6306-10.
9. 9. Katz AE, Olsson CA, Raffo AJ, et al. Molecular staging of prostate cancer with use of an enhanced reverse transcriptase-PCR assay. Urology 1994; 43: 765-75.
10. 10. Seiden MV, Kantoff PW, Krithivas K, et al. J Clin Oncol 1994; 12: 2634-9.
11. 11. Wood DP Jr., Banks ER, Humphreys S, McRoberts JW, Rangnekar VM. Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 1994; 74: 2533-40.
12. 12. Katz AE, de Vries GM, Begg MD, et al. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 1995; 75: 1642-8.
13. 13. Jaakkola S, Vornanen T, Leinonen J, Rannikko S, Stenman U. Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin Chem 1995; 41: 182-6.
14. 14. Ghossein RA, Scher HI, Gerald WL, et al. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 1995; 13: 1195-1200.
15. 15. Galvan B, Christopoulos TK, Diamandis EP. Detection of prostate specific antigen mRNA by reverse transcription polymerase chain reaction and time-resolved fluorometry. Clin Chem 1995; 41: 1705-9.
16. 16. Loric S, Dumas F, Eschwege P, et al. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin Chem 1995; 41: 1698-1704.
17. 17. Evangelista RA, Pollak A, Gudgin-Templeton EF. Enzyme amplified lanthanide luminescence for enzyme detection in bioanalytical assays. Anal Biochem 1991; 197: 213-24.
18. 18. Christopoulos TK, Diamandis EP. Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates. Anal Chem 1992; 64: 342-6.
19. 19. Okazaki T. Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay; comparison with dextran coated charcoal (DCC) assay and immunocytochemical assay. Jpn J Cancer Chemother 1992; 19: 361-6.
20. 20. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993; 15: 532-6.
21. 21. D'Aquila RT, Bechtel LJ, Videler JA, et al. Maximizing sensitivity and specificity of PCR by preamplification heating [Methods]. Nucleic Acids Res 1991; 19: 3749.
22. 22. Riegman PHJ, Klaassen P, van der Korput JAGM, Romijn JC, Trapman J. Molecular cloning and characterization of novel prostate antigen cDNAs. Biochem Biophys Res Commun 1988; 155: 181-8.
23. 23. Heston WDW. Detection of hematogenous dissemination of prostatic cancer by RT-PCR with primers specific for prostate-specific membrane antigen [Editorial]. Clin Chem 1995; 41: 1687-1688.
24. 24. Murphy LD, Herzog CE, Rudick JB, Fojo AT, Bates SE. Use of polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry 1990; 29: 10351-6.
25. 25. van Hille B, Lohre A, Reuter J, Herrmann R. Nonradioactive quantification of mdr1 mRNA by polymerase chain reaction amplification coupled with HPLC. Clin Chem 1995; 41: 1086-93.
26. 26. Diamandis EP, Yu H. Prostate cancer, prostate specific antigen and the polymerase chain reaction. Clin Chem 1995; 41: 177-9.
27. 27. Diamandis EP, Yu H. New biological functions of prostate specific antigen? J Clin Endocrinol Metab 1995; 80: 1515-7.
28. 28. Lehrer S, Terk M, Piccoli SP, et al. Reverse transcriptase-polymerase chain reaction for prostate specific antigen may be a prognostic indicator in breast cancer. Br J Cancer 1996; 74: 871-3.